ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
Interventions: BIOLOGICAL: ONTAK|OTHER: flow cytometry|OTHER: immunohistochemistry staining method|OTHER: enzyme-linked immunosorbent assay|OTHER: laboratory biomarker analysis|GENETIC: protein expression analysis
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)